Advanced search
Publication Cover
International Journal of General Medicine Volume 14, 2021 - Issue
Submit an article Journal homepage
83
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Impact of the COVID-19 Pandemic on the Management of Acute Myocardial Infarction

Jing HanDepartment of Cardiology and Macrovascular Disease, Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of ChinaView further author information
,
Ruofei JiaDepartment of Cardiology and Macrovascular Disease, Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of ChinaView further author information
,
Chengzhi YangDepartment of Cardiology and Macrovascular Disease, Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of ChinaView further author information
&
Zening JinDepartment of Cardiology and Macrovascular Disease, Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 3119-3124 | Published online: 02 Jul 2021

References

  • Yang C, Jin Z. An acute respiratory infection runs into the most common noncommunicable epidemic-COVID-19 and cardiovascular diseases. JAMA Cardiol. 2020;5(7):743. doi:10.1001/jamacardio.2020.0934
  • Li L, Hill J, Spratt JC, Jin Z. Myocardial injury in severe COVID-19: identification and management. Resuscitation. 2021;160:16–17. PMID: 33450334; PMCID: PMC7836289. doi:10.1016/j.resuscitation.2020.11.040
  • Li Z, Guan X, Mao N, et al. Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China. Lancet Reg Health West Pac. 2021;8:100094. PMID: 33585828; PMCID: PMC7864613. doi:10.1016/j.lanwpc.2021.100094
  • Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239. doi:10.1001/jama.2020.2648
  • Garcia S, Albaghdadi MS, Meraj PM, et al. Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J Am Coll Cardiol. 2020;75(22):2871–2872. doi:10.1016/j.jacc.2020.04.011
  • Tam CF, Cheung KS, Lam S, et al. Impact of Coronavirus Disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong, China. Circ Cardiovasc Qual Outcomes. 2020;13(4):e6631. doi:10.1161/CIRCOUTCOMES.120.006631
  • Hammad TA, Parikh M, Tashtish N, et al. Impact of COVID-19 pandemic on ST-elevation myocardial infarction in a non-COVID-19 epicenter. Catheter Cardiovasc Interv. 2020. doi:10.1002/ccd.28997
  • Xiang D, Xiang X, Zhang W, et al. Management and outcomes of patients with STEMI during the COVID-19 pandemic in China. J Am Coll Cardiol. 2020;76(11):1318–1324. PMID: 32828614; PMCID: PMC7438071. doi:10.1016/j.jacc.2020.06.039
  • Cao X, Spratt JC, Jin Z. Coronavirus disease 2019 (COVID-19) and acute cardiovascular disease management: a Chinese perspective on striking the balance. Resuscitation. 2020;152:36–38. doi:10.1016/j.resuscitation.2020.05.010
  • De Rosa S, Spaccarotella C, Basso C, et al.; Società Italiana di Cardiologia and the CCU Academy investigators group. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J. 2020;41(22):2083–2088. Erratum in: Eur Heart J. 2021 Feb 11;42(6):683. Erratum in: Eur Heart J. 2021 Jan 21;42(4):322. PMID: 32412631; PMCID: PMC7239145. doi:10.1093/eurheartj/ehaa409
  • Cosentino N, Bartorelli AL, Marenzi G. Time to treatment still matters in ST-elevation myocardial infarction: a call to maintain treatment effectiveness during the COVID-19 pandemic. Eur Heart J Cardiovasc Pharmacother. 2020;6(6):408–409. PMID: 32428204; PMCID: PMC7314092. doi:10.1093/ehjcvp/pvaa054
  • Cosentino N, Assanelli E, Merlino L, Mazza M, Bartorelli AL, Marenzi G. An in-hospital pathway for acute coronary syndrome patients during the COVID-19 outbreak: initial experience under real-world suboptimal conditions. Can J Cardiol. 2020;36(6):961–964. PMID: 32376346; PMCID: PMC7162765. doi:10.1016/j.cjca.2020.04.011

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.